30 April 2024
It is with heavy hearts that we share the devastating news of the passing of our beloved member of All.Can Belgium , David Gaier.
David was the governmental affairs and policy manager for BMS. In our executive board, he was deputy board member for Gilles Poncé , and he also served as a deputy member of the LCWG, alongside Bart Croes.
David contributed substantially to our organization, humbly behind the scenes.
We will always remember David for his profound kindness, his professionalism, his dedication, always ready to lend a helping hand. His commitment to make a positive impact in all he did, coupled with his innate kindness, have left an indelible mark on all who had the privilege to know him.
His presence among us will be deeply missed, and his memory will forever remain in our hearts.
During this difficult time, we extend our deepest condolences to his family and loved ones. May they find strength and solace in the memories of his love and the profound impact he made on the lives of others.
We will honor his memory by continuing to uphold the values he lived by and the positive impact he had on our organization.
Rest in peace, dear David. We are devastated by your loss, but forever grateful for the privilege of knowing you.
Every year, almost 9,000 women [1] undergo a cone biopsy to treat precancerous lesions. Precancerous lesions are abnormal cells in the cervix that can develop into cervical cancer. They are detected through cervical screening. A cone biopsy is preceded by a colposcopy – a closer examination of the cervix. In…
Anal cancer is rare, almost always linked to HPV, and in many cases preventable — if we detect precancerous lesions in time. In an in-depth interview, Dr. Magali Surmont (UZ Brussels) shares how Belgium is taking action against anal cancer. She points to three key areas where we can truly…
Since January 2025, cervical cancer screening for women aged 30 and over has been carried out differently. The smear is now first tested for the presence of human papillomavirus (HPV), and only then, depending on the result of that first test, are the cells examined. There is a good reason…
